# Pacific Biosciences (PACB) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/PACB
## Company Profile
- Ticker: PACB
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 1.3 USD
- Market cap: 490750667.04 USD
- Last updated: 2026-08-05
## Business Overview
### Long-Read Sequencing
Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics. Its HiFi technology reads long DNA fragments while maintaining high base-level accuracy.
### Sequencing Platforms
The company's instrument portfolio includes high-throughput Revio systems and benchtop Vega systems. Revenue combines instrument placements with recurring consumables, service and software. PacBio technology is used for whole-genome sequencing, rare-disease analysis, population genomics, microbial research and other applications where resolving structural variation and complex genomic regions is important.
## Why The Stock Is Moving

The latest monitored company update is “PacBio Appoints Mark Van Oene as President and Chief Executive Officer.” The corresponding closing-price reaction is not yet available.

## Future Catalysts

- PacBio's catalysts are Revio placements, HiFi sequencing adoption, and continued traction in clinical and translational workflows. The company needs to show that the high-accuracy platform is becoming sticky, not just interesting.

## Recent News
- 2026-08-05 20:08 EST — [PacBio Appoints Mark Van Oene as President and Chief Executive Officer](https://biopharmsignal.com/news/PACB/pacbio-appoints-mark-van-oene-as-president-and-chief-executive-officer-71597294) — Source: Pacific Biosciences
- 2026-08-05 20:05 EST — [PacBio Announces Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/PACB/pacbio-announces-second-quarter-2026-financial-results-d741855e) — Source: Pacific Biosciences
- 2026-08-05 13:05 EST — [PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system](https://biopharmsignal.com/news/PACB/pacbio-announces-faster-runs-up-to-50-more-hifi-data-and-new-compliance-controls-9380483d) — Source: Pacific Biosciences
- 2026-07-28 20:05 EST — [PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference](https://biopharmsignal.com/news/PACB/pacbio-to-participate-in-the-canaccord-genuity-46th-annual-growth-conference-4761c1ba) — Source: Pacific Biosciences
- 2026-07-15 20:05 EST — [PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026](https://biopharmsignal.com/news/PACB/pacbio-to-report-second-quarter-2026-financial-results-on-august-5-2026-ad299ae5) — Source: Pacific Biosciences